Why Is Apellis Pharmaceuticals (APLS) Down 1.9% Since Last Earnings Report?
Yahoo Finance · 5 days ago
Open | 41.53 |
High | 41.81 |
Low | 41.06 |
Mkt Cap | 5.05B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 41.70 |
52 Wk. Low | 19.83 |
52 Wk. High | 94.75 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 172.32M | 284.30% ▲ |
Net Income | -66.42M | - |
Diluted EPS | -0.54 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.32 | - |
Q1 2024 | -$0.47 | -$0.54 |
Q4 2023 | -$0.69 | -$0.73 |
S&P 500^GSPC | 5,346.33-14.46 (-0.27%) |
Dow 30^DJI | 38,647.75-220.29 (-0.57%) |
Nasdaq^IXIC | 17,196.85+4.32 (+0.03%) |
859.07-0.68% | |
0.3825+65.80% | |
Apple Inc.AAPL | 202.42+4.82% |